Vaughan Nelson Investment Management L.P. grew its position in UnitedHealth Group Inc (NYSE:UNH) by 2.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 451,721 shares of the healthcare conglomerate’s stock after purchasing an additional 11,345 shares during the period. UnitedHealth Group makes up approximately 1.3% of Vaughan Nelson Investment Management L.P.’s investment portfolio, making the stock its 17th largest holding. Vaughan Nelson Investment Management L.P.’s holdings in UnitedHealth Group were worth $98,167,000 at the end of the most recent reporting period.
Other institutional investors have also recently modified their holdings of the company. Selective Wealth Management Inc. acquired a new position in UnitedHealth Group during the third quarter worth approximately $27,000. North Star Investment Management Corp. acquired a new position in UnitedHealth Group during the third quarter worth approximately $30,000. Delta Asset Management LLC TN increased its position in UnitedHealth Group by 111.0% during the third quarter. Delta Asset Management LLC TN now owns 154 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 81 shares during the last quarter. Fusion Family Wealth LLC increased its position in UnitedHealth Group by 329.7% during the third quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 122 shares during the last quarter. Finally, Massey Quick Simon & CO. LLC increased its position in UnitedHealth Group by 212.5% during the third quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock worth $38,000 after buying an additional 119 shares during the last quarter. Institutional investors own 85.75% of the company’s stock.
Shares of UnitedHealth Group stock traded down $1.68 on Wednesday, hitting $253.57. The stock had a trading volume of 3,423,640 shares, compared to its average volume of 4,515,184. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94. The business’s 50 day moving average is $236.72 and its two-hundred day moving average is $241.62. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.67. The stock has a market cap of $243.46 billion, a price-to-earnings ratio of 19.69, a price-to-earnings-growth ratio of 1.36 and a beta of 0.61.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a $1.08 dividend. This represents a $4.32 annualized dividend and a dividend yield of 1.70%. UnitedHealth Group’s payout ratio is 33.54%.
A number of equities analysts have weighed in on UNH shares. UBS Group lowered their price target on UnitedHealth Group from $281.00 to $257.00 and set a “neutral” rating on the stock in a research report on Thursday, October 17th. Cantor Fitzgerald set a $310.00 price target on UnitedHealth Group and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Deutsche Bank started coverage on UnitedHealth Group in a research report on Thursday, September 12th. They set a “hold” rating and a $263.00 price target on the stock. Morgan Stanley lowered their price target on UnitedHealth Group from $298.00 to $294.00 and set an “overweight” rating on the stock in a research report on Thursday, September 26th. Finally, ValuEngine raised UnitedHealth Group from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $283.84.
In related news, Director Richard T. Burke sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $231.50, for a total value of $463,000.00. Following the completion of the sale, the director now directly owns 187,979 shares in the company, valued at $43,517,138.50. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CAO Thomas E. Roos sold 1,177 shares of the business’s stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $255.04, for a total value of $300,182.08. Following the completion of the sale, the chief accounting officer now owns 21,687 shares of the company’s stock, valued at $5,531,052.48. The disclosure for this sale can be found here. Insiders sold 33,177 shares of company stock worth $7,842,582 in the last ninety days. 0.82% of the stock is owned by company insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: What is the Current Ratio?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.